24起交易近50亿美元!艾伯维达成超20亿美元并购 | 一周交易

创鉴汇
Jul 10

据创鉴汇不完全统计,6月30日至7月6日全球生物制药领域共披露24起交易事件,潜在交易总额近50亿美元。上周最大金额的并购事件引人注目。艾伯维宣布以21亿美元收购Capstan Therapeutics,包括靶向脂质纳米颗粒(tLNP)技术平台及核心资产CAR-T疗法CPTX2309,加强免疫疾病领域的布局。CPTX2309将编码靶向CD19的嵌合抗原受体的mRNA载荷递送到表达CD8的T细胞中,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10